Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group

Valentin GoedeGerman CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany, ;Department of Geriatric Medicine, St. Marien Hospital, Cologne, Germany, Correspondence[email protected]

Raymonde BuschInstitute of Medical Statistics and Epidemiology, Technical University of Munich, Munich, Germany,

Jasmin BahloGerman CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany,

Viktoria ChatalineGerman CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany,

Stephan KremersDepartment of Hematology and Oncology, Caritas Hospital, Lebach, Germany,

Lothar MüllerPrivate Oncology Practice, Leer, Germany,

Daniel ReschkePrivate Oncology Practice, Oldenburg, Germany,

Rudolf SchlagPrivate Oncology Practice, Würzburg, Germany,

Burkhard SchmidtPrivate Oncology Practice, Munich, Germany,

Ursula Vehling-KaiserPrivate Oncology Practice, Landshut, Germany,

Ulrich WeddingDepartment of Palliative Care Medicine, University Hospital Jena, Jena, Germany,

Stefan StilgenbauerDepartment of Internal Medicine III, University of Ulm, Ulm, and

Michael HallekGerman CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany, ;Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), University of Cologne, Cologne, Germany

show all

Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Supplemental Tables and Figures

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Supplemental Tables and Figures

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date